FDA Joins More Device Collaborative Communities

FDA says it is participating in several new collaborative communities intended to address challenges in patient health care. An online notice says the communities are a continuing forum where private and public sector representatives of the community work together on medical device challenges to achieve common objectives and outcomes.

The agency currently participates in 12 collaborative communities, all established, managed, and controlled by external stakeholders, the notice says. The most recent collaborations focus on medical device development and product quality; understanding of valvular heart disease; innovations in digital pathology; reducing rates of intended self-injury and suicidal acts by people with diabetes; and strategies to increase the awareness, understanding, and participation of racial and ethnic minorities in the medical technology industry.